AstraZeneca gains stake in Swedish company with sale of respiratory drug

AstraZeneca gains stake in Swedish company with sale of respiratory drug - delawarebusinessnow.com

January 31, 2019

AstraZeneca gains stake in Swedish company with sale of respiratory drug delawarebusinessnow.com

Swedish Orphan Biovitrum AB (publ)(Sobi ) ( has completed the acquisition from AstraZeneca of rights to Synagis in the US as well as rights to participate in 50 ...

RSV Treatment

AstraZeneca gains stake in Swedish company with sale of respiratory drug - delawarebusinessnow.com

Comments

Post a Comment

Popular posts from this blog

Analysis | The Keys to Speed in Race for Vaccine, and Its Perils - Washington Post

Prematurity Awareness Month: Educating the public about Respiratory Syncytial Virus is vital, claims leading consultant - ZAWYA

Oishei Children's Hospital Seeing Spike in RSV Cases - Spectrum News